Partnering Opportunities with Denmark’s Life Science Clusters – an introduction Partnering Opportunities with Denmark’s Li...
Reasons for establishment in Denmark <ul><li>An excellent Danish Life Science cluster </li></ul><ul><li>Best business envi...
Denmark excels in Life Sciences activities <ul><li>No. 1  in Europe in terms of biotech patents as pct. of total patents (...
Drug Development Pipeline   Denmark has the 3rd largest commercial drug development pipeline in Europe (in actual numbers)...
<ul><li>10 science parks </li></ul><ul><li>8 universities </li></ul><ul><li>75 hospitals  </li></ul><ul><li>4 university h...
Danish strongholds – Biotech cluster   <ul><li>Metabolic diseases </li></ul><ul><li>Cancer </li></ul><ul><li>Inflammatory ...
<ul><li>Home of World-leading Novo Nordisk with 50 % of the world market of insulin. </li></ul><ul><li>100 year long tradi...
Metabolic Drug Development pipeline  Preclinical: 3 Research: 7 Phase I: 5 Phase II: 7 Phase III: 2 (Commercial drug devel...
World-class Competences in Cancer Research <ul><li>Medicon Valley is a world leader in cancer research </li></ul><ul><li>T...
Cancer Drug Development pipeline  Preclinical: 16 Research: 21 Phase I: 8 Phase II: 8 Phase III: 7 (Commercial drug develo...
<ul><li>Denmark has a strong presence of world-class academic research groups  </li></ul><ul><li>Denmark holds world compe...
Inflammatory and Infectious diseases  Drug Development pipeline  Preclinical: 25 Research: 6 Phase I: 6 Phase II: 15 Phase...
Pharmaceutical Companies with Production in Denmark <ul><li>Novo Nordisk </li></ul><ul><li>Biogen Idec </li></ul><ul><li>A...
<ul><li>From embryo to grave (electronic) health records </li></ul><ul><li>Unique access to patients, data, biobanks </li>...
DENMARK / MEDICON VALLEY – ONE OF EUROPE´S STRONGEST CLUSTERS
Additional Life Science centres in Denmark Pharmaceutical production Medical Technology production R&D centres
Europe’s best general business framework <ul><li>Flexicurity – easy hire and lay off practices </li></ul><ul><li>Best labo...
DENMARK IS AN ECONOMIC HIGH-FLYER 08-09-09 Global  Competitiveness Index   (WEF) World Competitiveness Scoreboard  (IMD) I...
Easy access <ul><li>131 direct flights </li></ul><ul><li>World’s best airport </li></ul><ul><li>Major investments in infra...
Benchmark of European locations
Our track record <ul><li>Invest in Denmark have facilitated significant Pharmaceutical </li></ul><ul><li>establishments in...
INVEST IN DENMARK - ORGANIZATION Management Development, Marketing & Communication North America Asia Europe Life  Science...
MISSION OF INVEST IN DENMARK <ul><li>To strengthen Danish competitiveness  </li></ul><ul><li>Creating new jobs in Denmark ...
<ul><li>How we assist Companies  </li></ul><ul><li>Identification of specific business opportunities  </li></ul><ul><li>Po...
How we assist Companies contd….. <ul><li>Information and analysis  </li></ul><ul><li>Contact potential partners, official ...
Danish Value Proposition Framework conditions Competences Establishment  in Denmark Better drugs faster Collaborate
Regional Directors (4) New York Paris Tokyo Shanghai Investment Managers (23 in 12 locations) New York   Paris   Tokyo   S...
Business Solutions  <ul><li>Choose DK for your next  R&D Center </li></ul><ul><li>Choose DK for your  SalesMarketing offic...
Thank you for your attention !
Upcoming SlideShare
Loading in …5
×

Invest in Denmark Lifescience Cluster- Intro

2,131 views

Published on

Published in: Travel, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,131
On SlideShare
0
From Embeds
0
Number of Embeds
13
Actions
Shares
0
Downloads
42
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Invest in Denmark Lifescience Cluster- Intro

  1. 1. Partnering Opportunities with Denmark’s Life Science Clusters – an introduction Partnering Opportunities with Denmark’s Life Science Clusters – An Introduction
  2. 2. Reasons for establishment in Denmark <ul><li>An excellent Danish Life Science cluster </li></ul><ul><li>Best business environment / framework </li></ul><ul><li>Assistance from Invest in Denmark </li></ul>
  3. 3. Denmark excels in Life Sciences activities <ul><li>No. 1 in Europe in terms of biotech patents as pct. of total patents (OECD, Biotechnology Statistics, 2006) </li></ul><ul><li>No. 2 in Europe on the Best performance Index of Biotechnology Innovation Scoreboard (European Commission 2002) </li></ul><ul><li>The 2nd largest commercial drug development pipeline in Europe (Ernst and Young, Beyond borders 2008) </li></ul>
  4. 4. Drug Development Pipeline Denmark has the 3rd largest commercial drug development pipeline in Europe (in actual numbers) (Ernst & Young 2009) Preclinical: 77 Research Phase I: 76 Phase II: 50 Phase III: 31 (Total Commercial drug development pipeline in Denmark Source: Invest in Denmark, Copenhagen Capacity 2009) Market
  5. 5. <ul><li>10 science parks </li></ul><ul><li>8 universities </li></ul><ul><li>75 hospitals </li></ul><ul><li>4 university hospitals </li></ul><ul><li>5,000 life science graduates annually </li></ul><ul><li>42,000 employees in the life science industry </li></ul><ul><li>More than 180 core biotech companies </li></ul><ul><li>More than 200 core medtech companies </li></ul><ul><li>18 CRO's </li></ul><ul><li>HQ of Novo Nordisk, Lundbeck, Leo Pharma, Novozymes, ALK Abelló, Danisco, Chr. Hansen. </li></ul>Danish life sciences at a glance
  6. 6. Danish strongholds – Biotech cluster <ul><li>Metabolic diseases </li></ul><ul><li>Cancer </li></ul><ul><li>Inflammatory and Infectious diseases </li></ul><ul><li>CNS </li></ul><ul><li>Vaccines and Immunotherapy </li></ul><ul><li>Clinical Trials </li></ul><ul><li>Technological Platforms </li></ul><ul><ul><li>Proteomics </li></ul></ul><ul><ul><li>Bioinformatics </li></ul></ul><ul><ul><li>Stemcells </li></ul></ul><ul><ul><li>Nanotechnology </li></ul></ul>
  7. 7. <ul><li>Home of World-leading Novo Nordisk with 50 % of the world market of insulin. </li></ul><ul><li>100 year long tradition in the production of insulin products </li></ul><ul><li>Significant range of academic research with several world class competencies. </li></ul><ul><li>Research groups spanning widely from basic to clinical research. </li></ul><ul><li>Many start-ups and close corporation between research institutions and companies. </li></ul>World-class Competencies in Metabolics Source: Commercial Attractiveness of Biomedical R&D in Medicon Valley – The Role of R&D in Attracting Regional Investments , The Boston Consulting Group, 2002. Novo Nordisk annual report 2004.
  8. 8. Metabolic Drug Development pipeline Preclinical: 3 Research: 7 Phase I: 5 Phase II: 7 Phase III: 2 (Commercial drug development pipeline in Denmark Source: Invest in Denmark, 2006) Company highlights: Novo Nordisk, Neurosearch, 7TM, Gastrotech, Rheoscience, Stevia Pharmaceuticals, Zealand Pharma etc.
  9. 9. World-class Competences in Cancer Research <ul><li>Medicon Valley is a world leader in cancer research </li></ul><ul><li>The first in Europe to develop breathing adapted radiation therapy of cancer patients (Copenhagen university hospital) </li></ul><ul><li>Medicon Valley is Europe’s strongest cluster in cancer R&D and comparable to Boston and Washington D.C. internationally </li></ul><ul><li>The world leading basic research teams of Jiri Bartek, Julio Celis and Marja Jäättelä are working in Copenhagen </li></ul>Source: Commercial Attractiveness of Biomedical R&D in Medicon Valley – The Role of R&D in Attracting Regional Investments , The Boston Consulting Group, 2002.
  10. 10. Cancer Drug Development pipeline Preclinical: 16 Research: 21 Phase I: 8 Phase II: 8 Phase III: 7 (Commercial drug development pipeline in Denmark Source: Invest in Denmark, 2006) Company examples: Novo Nordisk, Leo Pharma, Genmab, Santaris Pharma, Symphogen, TopoTarget, Neurosearch, Pharmexa, Cellcure, NatImmune etc.
  11. 11. <ul><li>Denmark has a strong presence of world-class academic research groups </li></ul><ul><li>Denmark holds world competencies in academic Inflammatory research – particular in arthritis and clinical research. </li></ul><ul><li>Denmark’s Inflammatory research is primarily driven by commercial interests with a high concentration of world class Inflammatory drug development companies </li></ul><ul><li>Many start-ups and close corporation between research institutions and companies. </li></ul>World-class competencies in Inflammatory Source: Commercial Attractiveness of Biomedical R&D in Medicon Valley – The Role of R&D in Attracting Regional Investments , The Boston Consulting Group, 2002.
  12. 12. Inflammatory and Infectious diseases Drug Development pipeline Preclinical: 25 Research: 6 Phase I: 6 Phase II: 15 Phase III: 7 (Commercial drug development pipeline in Denmark Source: Invest in Denmark, 2006) Company examples: Leo Pharma, TopoTarget, Action Pharma, Symphogen, 7TM, Pharmexa, Novozymes, Genmab, Arpida, Ace Biosciences etc.
  13. 13. Pharmaceutical Companies with Production in Denmark <ul><li>Novo Nordisk </li></ul><ul><li>Biogen Idec </li></ul><ul><li>Alpharma </li></ul><ul><li>Bavarian Nordic </li></ul><ul><li>Statens Serum Institute </li></ul><ul><li>CMC </li></ul><ul><li>NovoZymes </li></ul><ul><li>LEO Pharma </li></ul><ul><li>Nycomed </li></ul><ul><li>Ferring </li></ul><ul><li>Fertin </li></ul><ul><li>Ferrosan </li></ul>
  14. 14. <ul><li>From embryo to grave (electronic) health records </li></ul><ul><li>Unique access to patients, data, biobanks </li></ul><ul><li>Longstanding tradition for epidemiological studies </li></ul><ul><li>Personal ID registers/tracks, access to patient samples </li></ul><ul><li>Clinical infrastructure </li></ul><ul><li>Excellence in conducting clinical trials </li></ul><ul><li>Danish Medicines Agency one of the fastest to approve clinical trials </li></ul><ul><li>Clinical trials 40% cheaper than in the US </li></ul><ul><li>Access to grants (public-private partnerships) </li></ul><ul><li>Danish National Advanced Technology Foundation ($2.7 billion US) </li></ul><ul><li>Strategic Research Councils (specific RFP for Personalized Medicine) </li></ul><ul><li>Private foundations ($65 mill. US) </li></ul><ul><li>EU 7th Framework Programme ($10.4 billion US) </li></ul><ul><li>EU Innovative Medicines Initiative programme ($570 mill. US annually from 2007) </li></ul>Excellent Clinical Framework
  15. 15. DENMARK / MEDICON VALLEY – ONE OF EUROPE´S STRONGEST CLUSTERS
  16. 16. Additional Life Science centres in Denmark Pharmaceutical production Medical Technology production R&D centres
  17. 17. Europe’s best general business framework <ul><li>Flexicurity – easy hire and lay off practices </li></ul><ul><li>Best labor relations in the world </li></ul><ul><li>Human resources – English speaking population </li></ul><ul><li>World’s most motivated and best trained labor force </li></ul><ul><li>Flexible and cooperative government – no red tape </li></ul><ul><li>2nd most stable political environment in the world </li></ul><ul><li>25% corporate tax </li></ul><ul><li>3rd best infrastructure in the world </li></ul><ul><li>Economic top performer </li></ul>Source: IMD World Competitiveness Yearbook 2006
  18. 18. DENMARK IS AN ECONOMIC HIGH-FLYER 08-09-09 Global Competitiveness Index (WEF) World Competitiveness Scoreboard (IMD) Innovation Capability Index (UNCTAD) Best Place to do Business (EIU) 2007-2008 2007 2005 2008-2012 1 USA USA Sweden Denmark 2 Switzerland Singapore Finland Finland 3 Denmark Hong Kong USA Singapore 4 Sweden Luxembourg Denmark Canada 5 Germany Denmark Norway Switzerland 6 Finland Switzerland Australia Australia 7 Singapore Iceland Canada Hong Kong 8 Japan Netherlands UK Netherlands 9 United Kingdom Sweden Belgium Sweden 10 Netherlands Canada Netherlands USA
  19. 19. Easy access <ul><li>131 direct flights </li></ul><ul><li>World’s best airport </li></ul><ul><li>Major investments in infrastructure </li></ul><ul><li>World’s 5th largest conference city </li></ul>
  20. 20. Benchmark of European locations
  21. 21. Our track record <ul><li>Invest in Denmark have facilitated significant Pharmaceutical </li></ul><ul><li>establishments in Denmark </li></ul><ul><li>Some of these are: </li></ul><ul><li>Biogen Idec, Nordic HQ and European Manufacturing Centre </li></ul><ul><li>GBIF – Global Biodiversity Information Facility, world HQ </li></ul><ul><li>Genmab, HQ and development facility </li></ul><ul><li>Acadia Pharmaceuticals, R&D facility </li></ul><ul><li>Genzyme, Nordic HQ, R&D facility and production </li></ul><ul><li>Bio-Rad, Laboratories </li></ul><ul><li>Ferring Pharmaceuticals, R&D Centre </li></ul>
  22. 22. INVEST IN DENMARK - ORGANIZATION Management Development, Marketing & Communication North America Asia Europe Life Sciences ICT Hub Danmark Renewable Energy Support Quality Assurance Creative Denmark Maritime
  23. 23. MISSION OF INVEST IN DENMARK <ul><li>To strengthen Danish competitiveness </li></ul><ul><li>Creating new jobs in Denmark with a special focus on knowledge-intensive investments </li></ul><ul><li>Give the Danish business and research environment access to foreign strategic partners </li></ul>
  24. 24. <ul><li>How we assist Companies </li></ul><ul><li>Identification of specific business opportunities </li></ul><ul><li>Potential partners </li></ul><ul><li>Comprehensive fact base and decision-making support </li></ul><ul><li>Taxation, employment laws, regulatory issues </li></ul><ul><li>Local c ontacts </li></ul><ul><li>IP consultants, lawyers, authorities & public/private co-operation partners </li></ul><ul><li>Tools – unique benchmark, cost/benefit & logistic tools </li></ul>
  25. 25. How we assist Companies contd….. <ul><li>Information and analysis </li></ul><ul><li>Contact potential partners, official authorities, etc. </li></ul><ul><li>Arrange Fact-Finding Missions </li></ul><ul><li>Practical aid when setting up business </li></ul><ul><li>After Sales services </li></ul><ul><li>Complete Confidentiality and Free Value added services </li></ul>
  26. 26. Danish Value Proposition Framework conditions Competences Establishment in Denmark Better drugs faster Collaborate
  27. 27. Regional Directors (4) New York Paris Tokyo Shanghai Investment Managers (23 in 12 locations) New York Paris Tokyo Shanghai Sillicon Valley London Taipei Toronto Munich Seoul India Hong Kong Partner missions (15) Dublin Madrid Auckland Brussels Vienna Beijing The Hague Zürich New Delhi Tel Aviv Bern Singapore Rome Milan
  28. 28. Business Solutions <ul><li>Choose DK for your next R&D Center </li></ul><ul><li>Choose DK for your SalesMarketing office </li></ul><ul><li>Choose DK for Biopharmaceutical Production </li></ul><ul><li>Choose DK for your North European HQ </li></ul><ul><li>The Best Environment for conducting Clinical Trials </li></ul>
  29. 29. Thank you for your attention !

×